The clinical relevance of minor histocompatibility antigens in transplantation is disputed. High-throughput approaches are now being used to investigate the role of genome-wide genetic incompatibility in transplant outcomes. A recent study reports that donor and recipient mismatch at the LIMS1 locus is associated with an increased risk of acute rejection.
This is a preview of subscription content, log in via an institution to check access.
References
Opelz, G. & Collaborative Transplant Study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 365, 1570–1576 (2005).
Steers, N. J. et al. Genomic mismatch at LIMS1 locus and kidney allograft rejection. N. Engl. J. Med. 380, 1918–1928 (2019).
Reindl-Schwaighofer, R. et al. Mechanisms underlying human genetic diversity: consequence for antigraft antibody responses. Transpl. Int. 31, 239–250 (2018).
Xu, H., Cao, H. & Xiao, G. Signaling via PINCH: functions, binding partners and implications in human diseases. Gene 594, 10–15 (2016).
Yang, Y. et al. Formation and phosphorylation of the PINCH-1-integrin linked kinase-alpha-parvin complex are important for regulation of renal glomerular podocyte adhesion, architecture, and survival. J. Am. Soc. Nephrol. 16, 1966–1976 (2005).
Li, Y. et al. PINCH-1 promotes tubular epithelial-to-mesenchymal transition by interacting with integrin-linked kinase. J. Am. Soc. Nephrol. 18, 2534–2543 (2007).
Scanlan, M. J. et al. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int. J. Cancer 83, 456–464 (1999).
Reindl-Schwaighofer, R. et al. Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort. Lancet 393, 910–917 (2019).
Delville, M. et al. Early acute microvascular kidney transplant rejection in the absence of anti-HLA antibodies is associated with preformed IgG antibodies against diverse glomerular endothelial cell antigens. J. Am. Soc. Nephrol. 30, 692–709 (2019).
Wiebe, C. et al. Class II HLA epitope matching-A strategy to minimize de novo donor-specific antibody development and improve outcomes. Am. J. Transplant. 13, 3114–3122 (2013).
Acknowledgements
We acknowledge the generous help of A. Heinzel (Medical University of Vienna, Austria) in preparing this article. This work was supported by the Vienna Science and Technology Fund WWTF (grant # LS16-019 and # LS18-031) and the Österreichisch Nationalbank (grant # 17289).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Reindl-Schwaighofer, R., Oberbauer, R. Histocompatibility: minor differences have a major impact. Nat Rev Nephrol 15, 529–530 (2019). https://doi.org/10.1038/s41581-019-0175-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41581-019-0175-y
- Springer Nature Limited